PCRX Dec 2024 52.500 call
| Previous Close | 1.1000 |
| Open | 0.9000 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 52.50 |
| Expire Date | 2024-12-20 |
| Day's Range | 0.9000 - 1.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
Simply Wall St.Declining Stock and Decent Financials: Is The Market Wrong About Pacira BioSciences, Inc. (NASDAQ:PCRX)?
With its stock down 7.9% over the past month, it is easy to disregard Pacira BioSciences (NASDAQ:PCRX). However, stock...
GuruFocus.comInsider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing.
GlobeNewswirePacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, In
